Halozyme Therapeutics (HALO) PT Raised to $58 at Leerink Partners

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. SPY
7. CVS
8. UNH
9. AXP
10. ZETA

Go back to Halozyme Therapeutics (HALO) PT Raised to $58 at Leerink Partners

Halozyme Therapeutics (HALO) PT Raised to $73 at JMP Securities

November 1, 2024 3:42 AM EDT

JMP Securities analyst Jason Butler raised the price target on Halozyme Therapeutics (NASDAQ: HALO) to $73.00 (from $72.00) while maintaining a Market Outperform rating.... More

Halozyme Therapeutics (HALO) Tops Q3 EPS by 31c, provides guidance

October 31, 2024 4:03 PM EDT

Halozyme Therapeutics (NASDAQ: HALO) reported Q3 EPS of $1.27, $0.31 better than the analyst estimate of $0.96. Revenue for the quarter came in at $290 million versus the consensus estimate of $251.06 million.

GUIDANCE:

Halozyme Therapeutics sees FY2024 EPS of $4.00-$4.20, versus the consensus of $3.96.... More